Balance Sheet Data

ImmunoGen, Inc. (IMGN)

$31.235

+0.01 (+0.02%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 262.25176.22293.86275.14275.14410.43541.64714.80943.311,244.88
Total Cash (%)
Account Receivables 12.0727.2522.5017.9817.9830.3240.0152.8069.6991.96
Account Receivables (%)
Inventories -16.53-32.67-30.4016.20-28.98-30.19-39.85-52.58-69.39-91.58
Inventories (%)
Accounts Payable 11.379.939.5445.3545.3535.5446.9061.9081.69107.80
Accounts Payable (%)
Capital Expenditure -5.25-2.85-0.92-1.36-1.36-4.71-6.22-8.20-10.83-14.29
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.